Legislation sponsored by a local state representative to expand the scope of ovarian cancer screenings has been signed into law.
State Rep. Norine Hammond’s (R-Macomb) House Bill 4203 adds having a high level of CA-125, as indicated by a blood test screening, to the definition of “at risk for ovarian cancer.” It provides that “surveillance tests for ovarian cancer” means all medically viable methods for the detection and diagnosis of ovarian cancer, including, but not limited to, ultrasounds, MRIs, x-rays, CT scans, and CA-125 blood test screenings.
The bill was unanimously approved by the Illinois House and Senate and was signed into law by Gov. JB Pritzker on Friday.